Skip to main content
NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
0.610
+0.004 (0.64%)
Apr 29, 2026, 10:42 AM EDT - Market open

NEXGEL Revenue

In the year 2025, NEXGEL had annual revenue of $11.42M with 31.46% growth. NEXGEL had revenue of $2.80M in the quarter ending December 31, 2025, a decrease of -8.06%.

Revenue (ttm)
$11.42M
Revenue Growth
+31.46%
P/S Ratio
0.45
Revenue / Employee
$601,105
Employees
19
Market Cap
5.17M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202511.42M2.73M31.46%
Dec 31, 20248.69M4.60M112.47%
Dec 31, 20234.09M2.04M99.66%
Dec 31, 20222.05M497.00K32.04%
Dec 31, 20211.55M877.00K130.12%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Harvard Bioscience 86.55M
Retractable Technologies 38.27M
Bionano Genomics 28.51M
Jin Medical International 20.69M
Nephros 18.79M
Milestone Scientific 8.97M
Lucyd 2.66M
Femasys 2.29M
Revenue Rankings

NXGL News

More News